Trials / Completed
CompletedNCT01402830
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 271 (actual)
- Sponsor
- Janssen-Cilag, S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.
Detailed description
This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Visual analogue scales (EVAs) | This scale measures the pain intensity. |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2011-07-26
- Last updated
- 2013-02-11
Source: ClinicalTrials.gov record NCT01402830. Inclusion in this directory is not an endorsement.